Medmen Enterprises Inc
Change company Symbol lookup
Select an option...
MMNFF Medmen Enterprises Inc
J Jacobs Engineering Group Inc
HOV Hovnanian Enterprises Inc
ELCR Electric Car Company Inc
EMO ClearBridge Energy Midstream Opportunity Fund
BA Boeing Co
ROIC Retail Opportunity Investments Corp
BEPH Brookfield BRP Holdings (Canada) Inc
WRB W R Berkley Corp
TTWO Take-Two Interactive Software Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

MedMen Enterprises Inc. is a Canada-based cannabis retailer. The Company operates across the United States and stores in Los Angeles, Las Vegas and New York. It offers products under various categories, such as LuxLyte, MedMen, AlienLabs, Atlas, Bad Apple, Bloom, Breez, Caliva, BEBOE and Bic. It offers products under various categories, such as accessories, apparel, beverages, concentrates, edibles, flower, pets, pre rolls, topicals and vaporizers. It also offers products under various strain, such as Hybrid, Indica, Indica Dominant, Sativa and Sativa Dominant.

Closing Price
$0.2096
Day's Change
-0.0105 (-4.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.227
Day's Low
0.2025
Volume
(Heavy Day)
Volume:
7,152,980

10-day average volume:
2,333,919
7,152,980

Display:

Providers:

UpdateCancel
4 providers
October 19, 2021
Cannabis edibles maker Wana Brands looks to promote more social causes after $298 million upfront payment from Canopy Growth

Steve Gelsi Wana Brands founder sells buy option to Canopy Growth as she eyes more growth for the edibles company. Wana Brands founder Nancy Whiteman has been called the Martha Stewart of pot edibles, but she told MarketWatch she's...(MarketWatch)

August 24, 2021
Pot and poppy paintings: Inside a cannabis lifestyle company's 'immersive' Van Gogh exhibit

Steve Gelsi Party hosting company Happy Munkey holds cannabis-inspired gathering at NYC's Original Immersive Van Gogh Exhibit with branded, pre-rolled joints included in VIP gift bags (MarketWatch)

August 18, 2021
Analysts upbeat on Tilray's U.S. prospects after MedMen deal

Steve Gelsi Tilray stock rallies after Alliance Global's Grey said the deal, at a 'reasonable price,' positions company for stronger growth Shares of Tilray Inc. rallied Wednesday, on the heels of mostly positive analyst comments on...(MarketWatch)

Tilray eyes U.S. cannabis market with MedMen move, stock gains

By Jeremy C. Owens Canadian pot company buying convertible notes of downtrodden U.S. brand as Tilray seeks approval to issue more shares for deal Canadian cannabis company Tilray Inc. has its eyes on the U.S. (MarketWatch)

July 17, 2021
Want to invest in U.S. pot stocks? Here's what you need to know

For this reason, Company B is absolutely the better long-term play -- particularly if those two dispensaries are in markets that are in the process of legalizing cannabis like New York or New Jersey, that offer greater upside. (MarketWatch)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.